The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?
Communist China has the USA in a resource stranglehold. They have a monopoly on this CRITICAL metal that we desperately need for military technology. In fact, both Trump AND Biden passed executive orders that addressed this crisis. And it could have a massive effect on smart investor's bank accounts.
See This Growing National Security Threat Here

WINT Insider Trading (Windtree Therapeutics)

Insider Ownership Percentage: 16.71%
Insider Buying (Last 12 Months): $120,842.30
Insider Selling (Last 12 Months): $0.00

Windtree Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Windtree Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Windtree Therapeutics Share Price & Price History

Current Price: $0.42
Price Change: Price Increase of +0.026 (6.55%)
As of 08/11/2022 01:43 PM ET

This chart shows the closing price history over time for WINT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
Discover this company's HUGE lithium potential

Windtree Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/26/2022Craig FraserCEOBuy2,500$0.37$925.00224,058View SEC Filing Icon  
7/26/2022John P HamillCFOBuy3,000$0.37$1,110.0072,800View SEC Filing Icon  
6/29/2022Craig FraserCEOBuy7,000$0.42$2,940.00217,058View SEC Filing Icon  
3/15/2022Craig FraserCEOBuy3,000$0.98$2,940.00View SEC Filing Icon  
3/15/2022Steven SimonsonSVPBuy5,000$1.00$5,000.00View SEC Filing Icon  
11/18/2021Craig FraserCEOBuy930$1.61$1,497.30View SEC Filing Icon  
10/22/2021Craig FraserCEOBuy3,000$1.90$5,700.00View SEC Filing Icon  
10/19/2021Craig FraserCEOBuy3,000$1.91$5,730.00View SEC Filing Icon  
10/19/2021James HuangDirectorBuy50,000$1.90$95,000.00View SEC Filing Icon  
4/16/2021John P HamillCFOBuy1,000$2.07$2,070.0029,298View SEC Filing Icon  
4/7/2021Eric CurtisCOOBuy791$2.52$1,993.321,291View SEC Filing Icon  
4/5/2021Craig FraserCEOBuy1,000$2.58$2,580.0027,798View SEC Filing Icon  
3/31/2021Craig FraserCEOBuy500$2.32$1,160.0026,298View SEC Filing Icon  
3/31/2021James HuangDirectorBuy150,000$2.36$354,000.00171,000View SEC Filing Icon  
3/25/2021Steven SimonsonSVPBuy1,500$3.25$4,875.0012,302View SEC Filing Icon  
10/28/2020Craig FraserCEOBuy250$6.56$1,640.0024,298View SEC Filing Icon  
10/23/2020James HuangDirectorBuy1,000$6.67$6,670.0021,000View SEC Filing Icon  
10/9/2020Craig FraserCEOBuy250$5.83$1,457.5024,048View SEC Filing Icon  
10/8/2020Eric CurtisCOOBuy500$5.27$2,635.00500View SEC Filing Icon  
10/7/2020Craig FraserCEOBuy250$5.17$1,292.5023,798View SEC Filing Icon  
10/7/2020John P HamillCFOBuy1,000$5.27$5,270.001,000View SEC Filing Icon  
6/3/2020James HuangDirectorBuy200$7.42$1,484.008,000View SEC Filing Icon  
1/17/2020James HuangDirectorBuy2,058$4.45$9,158.10
12/30/2019James HuangDirectorBuy5,000$4.25$21,250.00
See Full Table
Investors Look to Capitalize on the Budding Green Revolution
Lithium is the uncontested fuel of the green energy revolution. One little-known small-cap lithium mining company in a renowned South American location has started attracting interest from opportunity-minded investors.
Discover this company's HUGE lithium potential

SEC Filings (Institutional Ownership Changes) for Windtree Therapeutics (NASDAQ:WINT)

11.37% of Windtree Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at WINT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Windtree Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC234,446$0.27M0.0%+8.8%0.797%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.551,274$0.63M0.0%-17.8%1.874%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC187,400$0.39M0.0%+28.6%0.702%Search for SEC Filing on Google Icon
11/10/2021Skandinaviska Enskilda Banken AB publ110,500$0.23M0.0%+15.7%0.414%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.49,708$0.10M0.0%-13.6%0.186%Search for SEC Filing on Google Icon
8/16/2021State Street Corp19,300$44K0.0%N/A0.072%Search for SEC Filing on Google Icon
8/16/2021Frontier Wealth Management LLC60,000$0.14M0.0%N/A0.225%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.66,952$0.15M0.0%N/A0.251%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC145,700$0.33M0.0%+1,156.0%0.546%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp65,380$0.15M0.0%+28.8%0.245%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC69,082$0.16M0.0%N/A0.259%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.626,057$1.43M0.0%+16.1%2.344%Search for SEC Filing on Google Icon
8/10/2021Skandinaviska Enskilda Banken AB publ95,500$0.22M0.0%N/A0.364%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC66,035$0.16M0.0%N/A0.251%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC66,035$0.16M0.0%N/A0.251%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP23,365$57K0.0%N/A0.089%Search for SEC Filing on Google Icon
5/14/2021PVG Asset Management Corp63,795$0.16M0.5%N/A0.243%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC11,600$28K0.0%N/A0.044%Search for SEC Filing on Google Icon
5/13/2021Kepos Capital LP165,000$0.40M0.0%+83.3%0.628%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp50,743$0.13M0.0%-29.9%0.193%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.36,334$89K0.0%N/A0.138%Search for SEC Filing on Google Icon
3/9/2021tru Independence LLC60,000$0.31M0.0%N/A0.355%Search for SEC Filing on Google Icon
2/16/2021Paloma Partners Management Co18,469$95K0.0%-50.2%0.109%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp72,385$0.37M0.0%-11.3%0.428%Search for SEC Filing on Google Icon
11/17/2020Paloma Partners Management Co37,090$0.20M0.0%N/A0.220%Search for SEC Filing on Google Icon
8/14/2020Deerfield Management Company L.P. Series C20,148$0.14M0.0%N/A0.147%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG3,498$25K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/15/2017Sabby Management LLC287,522$0.33M0.0%-14.0%3.046%Search for SEC Filing on Google Icon
5/15/2017Broadfin Capital LLC777,797$0.89M0.1%No Change8.240%Search for SEC Filing on Google Icon
2/14/2017Broadfin Capital LLC777,797$0.97M0.1%No Change9.176%Search for SEC Filing on Google Icon
2/10/2017FMR LLC224,091$0.28M0.0%No Change2.644%Search for SEC Filing on Google Icon
11/14/2016Baker BROS. Advisors LP254,973$0.65M0.0%N/A3.069%Search for SEC Filing on Google Icon
8/15/2016Sabby Management LLC448,509$0.87M0.0%N/A5.450%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Windtree Therapeutics logo
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase IIb clinical trial for the treatment of genetically associated hypertension. It has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. is a subsidiary of Lee's Pharmaceutical Holdings Limited.
Read More on Windtree Therapeutics

Today's Range

Now: $0.42
Low: $0.40
High: $0.43

50 Day Range

MA: $0.42
Low: $0.37
High: $0.49

52 Week Range

Now: $0.42
Low: $0.35
High: $2.37

Volume

983 shs

Average Volume

178,883 shs

Market Capitalization

$12.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.33

Who are the company insiders with the largest holdings of Windtree Therapeutics?

Windtree Therapeutics' top insider investors include:
  1. Craig Fraser (CEO)
  2. James Huang (Director)
  3. John P Hamill (CFO)
  4. Steven Simonson (SVP)
  5. Eric Curtis (COO)
Learn More about top insider investors at Windtree Therapeutics.
How High Can Copper Go?
To power the green revolution, copper demand continues to skyrocket with no end in sight. Prices hit a 10-year high; as copper jumped 79% in the past year. Some analysts are calling for copper to rise another 50-100%! We may be at the beginning of a copper bull run the likes we've never seen before. Just how high can copper go?
Find Out in this Research Report.